Loading Curie Briefs...
Getting the latest healthcare news for you
Getting the latest healthcare news for you
Men who visit their primary care doctor with prostate symptoms are more likely to be diagnosed with clinically significant prostate cancer than those flagged through routine PSA testing. A large UK study found symptomatic men had 59% higher odds of any prostate cancer diagnosis and 14% higher odds of a clinically significant case within two years. Disease stage and mortality risk were similar between both groups.
When symptoms speak, doctors should listen — especially when it comes to prostate cancer. A large UK retrospective study found that men presenting to primary care with prostate-related symptoms (like urinary issues, blood in urine, or erectile dysfunction) were significantly more likely to be diagnosed with clinically significant prostate cancer within 24 months, compared to asymptomatic men detected through opportunistic PSA testing.
The study, published in the British Journal of General Practice, analyzed data from over 722,000 men aged 50 and older. Symptomatic men had 59% higher odds of any prostate cancer diagnosis and 14% higher odds of a clinically significant diagnosis (Gleason grade group ≥3). However, disease stage at diagnosis and prostate cancer mortality were similar between the two groups — suggesting symptoms don't necessarily mean a later catch.
By the Numbers:
Why it matters: This study suggests that symptomatic and asymptomatic patients may need different diagnostic approaches in primary care. Tailoring strategies based on how a patient presents — rather than applying a one-size-fits-all PSA screening model — could improve detection and outcomes for prostate cancer.
